Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on resistance to subsequent viral challenge in calves

Amelia R. Woolums Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Amelia R. Woolums in
Current site
Google Scholar
PubMed
Close
 DVM, MVSc, PhD
,
Corrie C. Brown Department of Veterinary Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Corrie C. Brown in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
James C. Brown Jr Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
Present address is the Department of Veterinary Clinical Sciences, College Office of Research, The Ohio State University, 601 Vernon L. Tharp St, Columbus, OH 43210.

Search for other papers by James C. Brown Jr in
Current site
Google Scholar
PubMed
Close
 DVM
,
Dana J. Cole Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Dana J. Cole in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Melissa A. Scott Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
Present address is the Southeast Poultry Research Laboratory, USDA, 934 College Station Rd, Athens, GA 30605.

Search for other papers by Melissa A. Scott in
Current site
Google Scholar
PubMed
Close
 MS
,
Shamita M. Williams Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Shamita M. Williams in
Current site
Google Scholar
PubMed
Close
 BS
, and
Congrong Miao Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
Present address is the Respiratory Viruses Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333.

Search for other papers by Congrong Miao in
Current site
Google Scholar
PubMed
Close
 MS

Click on author name to view affiliation information

Abstract

Objective—To determine whether a single intranasal dose of modified-live bovine respiratory syncytial virus (BRSV) vaccine protects calves from BRSV challenge and characterize cell-mediated immune response in calves following BRSV challenge.

Animals—13 conventionally reared 4- to 6-week-old Holstein calves.

Procedure—Calves received intranasal vaccination with modified live BRSV vaccine (VC-group calves; n = 4) or mock vaccine (MC-group calves; 6) 1 month before BRSV challenge; unvaccinated control-group calves (n = 3) underwent mock challenge. Serum virus neutralizing (VN) antibodies were measured on days –30, -14, 0, and 7 relative to BRSV challenge; nasal swab specimens were collected for virus isolation on days 0 to 7. At necropsy examination on day 7, tissue specimens were collected for measurement of BRSV-specific interferon gamma (IFN-γ) production. Tissue distribution of CD3+ T and BLA.36+ B cells was evaluated by use of immunohistochemistry.

Results—The MC-group calves had significantly higher rectal temperatures, respiratory rates, and clinical scores on days 5 to 7 after BRSV challenge than VCgroup calves. No difference was seen between distributions of BRSV in lung tissue of VC- and MC-group calves. Production of BRSV-specific IFN-γ was increased in tissue specimens from VC-group calves, compared with MC- and control-group calves. Virusspecific IFN-γ production was highest in the mediastinal lymph node of VC-group calves. Increased numbers of T cells were found in expanded bronchialassociated lymphoid tissue and airway epithelium of VC-group calves.

Conclusions and Clinical Relevance—An intranasal dose of modified-live BRSV vaccine can protect calves against virulent BRSV challenge 1 month later. ( Am J Vet Res 2004;65:363–372)

Abstract

Objective—To determine whether a single intranasal dose of modified-live bovine respiratory syncytial virus (BRSV) vaccine protects calves from BRSV challenge and characterize cell-mediated immune response in calves following BRSV challenge.

Animals—13 conventionally reared 4- to 6-week-old Holstein calves.

Procedure—Calves received intranasal vaccination with modified live BRSV vaccine (VC-group calves; n = 4) or mock vaccine (MC-group calves; 6) 1 month before BRSV challenge; unvaccinated control-group calves (n = 3) underwent mock challenge. Serum virus neutralizing (VN) antibodies were measured on days –30, -14, 0, and 7 relative to BRSV challenge; nasal swab specimens were collected for virus isolation on days 0 to 7. At necropsy examination on day 7, tissue specimens were collected for measurement of BRSV-specific interferon gamma (IFN-γ) production. Tissue distribution of CD3+ T and BLA.36+ B cells was evaluated by use of immunohistochemistry.

Results—The MC-group calves had significantly higher rectal temperatures, respiratory rates, and clinical scores on days 5 to 7 after BRSV challenge than VCgroup calves. No difference was seen between distributions of BRSV in lung tissue of VC- and MC-group calves. Production of BRSV-specific IFN-γ was increased in tissue specimens from VC-group calves, compared with MC- and control-group calves. Virusspecific IFN-γ production was highest in the mediastinal lymph node of VC-group calves. Increased numbers of T cells were found in expanded bronchialassociated lymphoid tissue and airway epithelium of VC-group calves.

Conclusions and Clinical Relevance—An intranasal dose of modified-live BRSV vaccine can protect calves against virulent BRSV challenge 1 month later. ( Am J Vet Res 2004;65:363–372)

All Time Past Year Past 30 Days
Abstract Views 52 0 0
Full Text Views 549 393 45
PDF Downloads 212 89 12
Advertisement